399 related articles for article (PubMed ID: 30400384)
21. Noninvasive interference tear meniscometry in dry eye patients with Sjögren syndrome.
Uchida A; Uchino M; Goto E; Hosaka E; Kasuya Y; Fukagawa K; Dogru M; Ogawa Y; Tsubota K
Am J Ophthalmol; 2007 Aug; 144(2):232-237. PubMed ID: 17533107
[TBL] [Abstract][Full Text] [Related]
22. Infrared imaging of meibomian glands and evaluation of the lipid layer in Sjögren's syndrome patients and nondry eye controls.
Menzies KL; Srinivasan S; Prokopich CL; Jones L
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):836-41. PubMed ID: 25574045
[TBL] [Abstract][Full Text] [Related]
23. Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.
Aqrawi LA; Galtung HK; Vestad B; Øvstebø R; Thiede B; Rusthen S; Young A; Guerreiro EM; Utheim TP; Chen X; Utheim ØA; Palm Ø; Jensen JL
Arthritis Res Ther; 2017 Jan; 19(1):14. PubMed ID: 28122643
[TBL] [Abstract][Full Text] [Related]
24. Manifestation of meibomian gland dysfunction in patients with Sjögren's syndrome, non-Sjögren's dry eye, and non-dry eye controls.
Kang YS; Lee HS; Li Y; Choi W; Yoon KC
Int Ophthalmol; 2018 Jun; 38(3):1161-1167. PubMed ID: 28567496
[TBL] [Abstract][Full Text] [Related]
25. Association of IL-21 cytokine with severity of primary Sjögren syndrome dry eye.
Lim SA; Nam DH; Lee JH; Kwok SK; Park SH; Chung SH
Cornea; 2015 Mar; 34(3):248-52. PubMed ID: 25603233
[TBL] [Abstract][Full Text] [Related]
26. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes.
Baldini C; Giusti L; Ciregia F; Da Valle Y; Giacomelli C; Donadio E; Sernissi F; Bazzichi L; Giannaccini G; Bombardieri S; Lucacchini A
Arthritis Res Ther; 2011; 13(6):R194. PubMed ID: 22117835
[TBL] [Abstract][Full Text] [Related]
27. Tear and saliva ferning tests in Sjögren's syndrome (SS).
Maragou M; Vaikousis E; Ntre A; Koronis N; Georgiou P; Hatzidimitriou E; Sotsiou F; Dantis P
Clin Rheumatol; 1996 Mar; 15(2):125-32. PubMed ID: 8777844
[TBL] [Abstract][Full Text] [Related]
28. Tear osmolarity in Sjögren syndrome.
Bunya VY; Langelier N; Chen S; Pistilli M; Vivino FB; Massaro-Giordano G
Cornea; 2013 Jul; 32(7):922-7. PubMed ID: 23407318
[TBL] [Abstract][Full Text] [Related]
29. A proposal of new ocular items in Sjögren's syndrome classification criteria.
Versura P; Frigato M; Mulé R; Malavolta N; Campos EC
Clin Exp Rheumatol; 2006; 24(5):567-72. PubMed ID: 17181927
[TBL] [Abstract][Full Text] [Related]
30. Tear Lysozyme in Sjögren´s syndrome, Meibomian gland dysfunction, and non-dry-eye.
Berra M; Galperín G; Berra F; Marquez MI; Mandaradoni M; Tau J; Berra A
Arq Bras Oftalmol; 2021; 85(2):103-108. PubMed ID: 34431892
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic performance of tear function tests in Sjogren's syndrome patients.
Versura P; Frigato M; Cellini M; Mulè R; Malavolta N; Campos EC
Eye (Lond); 2007 Feb; 21(2):229-37. PubMed ID: 16397619
[TBL] [Abstract][Full Text] [Related]
32. Correlation between dry eye and rheumatoid arthritis activity.
Fujita M; Igarashi T; Kurai T; Sakane M; Yoshino S; Takahashi H
Am J Ophthalmol; 2005 Nov; 140(5):808-13. PubMed ID: 16289424
[TBL] [Abstract][Full Text] [Related]
33. Tear evaporation rates in Sjögren syndrome and non-Sjögren dry eye patients.
Goto E; Matsumoto Y; Kamoi M; Endo K; Ishida R; Dogru M; Kaido M; Kojima T; Tsubota K
Am J Ophthalmol; 2007 Jul; 144(1):81-85. PubMed ID: 17509507
[TBL] [Abstract][Full Text] [Related]
34. Tear miRNAs Identified in a Murine Model of Sjögren's Syndrome as Potential Diagnostic Biomarkers and Indicators of Disease Mechanism.
Kakan SS; Edman MC; Yao A; Okamoto CT; Nguyen A; Hjelm BE; Hamm-Alvarez SF
Front Immunol; 2022; 13():833254. PubMed ID: 35309364
[TBL] [Abstract][Full Text] [Related]
35. Degradation of proteoglycan 4/lubricin by cathepsin S: Potential mechanism for diminished ocular surface lubrication in Sjögren's syndrome.
Regmi SC; Samsom ML; Heynen ML; Jay GD; Sullivan BD; Srinivasan S; Caffery B; Jones L; Schmidt TA
Exp Eye Res; 2017 Aug; 161():1-9. PubMed ID: 28549901
[TBL] [Abstract][Full Text] [Related]
36. Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of patients with dry eye syndrome.
Yoon KC; Park CS; You IC; Choi HJ; Lee KH; Im SK; Park HY; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):643-50. PubMed ID: 19850844
[TBL] [Abstract][Full Text] [Related]
37. Expression of Lipid Peroxidation Markers in the Tear Film and Ocular Surface of Patients with Non-Sjogren Syndrome: Potential Biomarkers for Dry Eye Disease.
Choi W; Lian C; Ying L; Kim GE; You IC; Park SH; Yoon KC
Curr Eye Res; 2016 Sep; 41(9):1143-9. PubMed ID: 26731289
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of lipid oxidative stress status in Sjögren syndrome patients.
Wakamatsu TH; Dogru M; Matsumoto Y; Kojima T; Kaido M; Ibrahim OM; Sato EA; Igarashi A; Ichihashi Y; Satake Y; Shimazaki J; Tsubota K
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):201-10. PubMed ID: 23150615
[TBL] [Abstract][Full Text] [Related]
39. Ocular surface injuries in autoimmune dry eye. The severity of microscopical disturbances goes parallel with the severity of symptoms of dryness.
Cejková J; Ardan T; Cejka C; Malec J; Jirsová K; Filipec M; Ruzicková E; Dotrelová D; Brunová B
Histol Histopathol; 2009 Oct; 24(10):1357-65. PubMed ID: 19688700
[TBL] [Abstract][Full Text] [Related]
40. Utility of Novel Autoantibodies in the Diagnosis of Sjögren's Syndrome Among Patients With Dry Eye.
Karakus S; Baer AN; Agrawal D; Gurakar M; Massof RW; Akpek EK
Cornea; 2018 Apr; 37(4):405-411. PubMed ID: 29504954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
